Kestra Medical Technologies filings document the public-company disclosures of a Bermuda-incorporated medical technology issuer listed on Nasdaq under KMTS. Its Form 8-K reports have furnished quarterly and annual financial results, revenue guidance, and Regulation FD disclosures tied to the ASSURE WCD and ACE-PAS post-approval study results.
The company’s proxy materials and annual meeting filings cover board elections, independent auditor ratification, shareholder voting results, and equity compensation matters, including the 2025 Employee Stock Purchase Plan. These records also identify governance procedures and formal shareholder actions for the wearable defibrillator and digital health business.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.77%
Tags
FAQ
How many KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) SEC filings are available on StockTitan?
StockTitan tracks 121 SEC filings for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)?
The most recent SEC filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) was filed on November 5, 2026.